Physician profile
James Stannard
NPI 1720030190
$67,511.36
in general payments reported to CMS, 2019-2025
11 companies · $18K in 2025
The $18K reported for 2025 was more than what 90% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,380 · 2020: $20K · 2021: $2,699 · 2022: $5,030 · 2023: $10K · 2024: $6,129 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $13K · Consulting Fee: $9,796 · Travel and Lodging: $9,464 · Food and Beverage: $1,757 · Education: $923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,824.00 |
| Consulting Fee | $9,795.76 |
| Travel and Lodging | $9,464.38 |
| Food and Beverage | $1,756.92 |
| Education | $923.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $35,089.37 | 2020-2025 | |
| Medical Device Business Services, INC. | $28,040.79 | 2019-2025 | Actis, Na, Tfn-Advance |
| Elite Orthopedics, LLC | $2,401.93 | 2019-2024 | |
| Depuy Synthes Sales INC. | $1,146.52 | 2019-2025 | Na, Tfn-Advance, Lcp |
| Arthrex, INC. | $268.28 | 2022-2024 | |
| Organogenesis INC. | $227.17 | 2021-2023 | Puraply |
| Kerecis Limited | $93.67 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Endeavor Orthopaedics LLC | $80.98 | 2025 | Summit Patella Plating System |
| Depuy Synthes Products, INC. | $71.00 | 2022 | |
| Medtronic USA, INC. | $69.17 | 2020 | |
| Lifenet Health | $22.48 | 2024 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Stannard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.